Arcus Biosciences, Inc. (RCUS)
22.97
-0.86
(-3.61%)
USD |
NYSE |
Jan 02, 12:37
Arcus Biosciences Research and Development Expense (TTM): 503.00M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Gilead Sciences, Inc. | 5.734B |
| Actinium Pharmaceuticals, Inc. | 20.82M |
| Madrigal Pharmaceuticals, Inc. | 296.43M |
| Karyopharm Therapeutics, Inc. | 130.89M |
| Janux Therapeutics, Inc. | 115.15M |